MARKET

SRRK

SRRK

Scholar Rock Holding
NASDAQ
53.78
-0.92
-1.68%
After Hours: 54.72 +0.94 +1.75% 18:30 07/14 EDT
OPEN
54.71
PREV CLOSE
54.70
HIGH
55.46
LOW
53.64
VOLUME
1.09M
TURNOVER
--
52 WEEK HIGH
58.49
52 WEEK LOW
27.07
MARKET CAP
6.44B
P/E (TTM)
-15.6042
1D
5D
1M
3M
1Y
5Y
1D
Biotech Stocks At 52-Week Highs: AMWL, CUE, ICCC, SRRK, FTH
NASDAQ · 1d ago
Weekly Report: what happened at SRRK last week (0706-0710)?
Weekly Report · 1d ago
Scholar Rock Holding (SRRK) Rallies As Pipeline Story Meets A Fair Value Question
Simply Wall St · 2d ago
Weekly Report: what happened at SRRK last week (0629-0703)?
Weekly Report · 07/06 10:06
Scholar Rock Holding (SRRK) Receives a Buy from Wedbush
TipRanks · 06/29 12:36
Weekly Report: what happened at SRRK last week (0622-0626)?
Weekly Report · 06/29 10:02
Scholar Rock: New Treatment Boost For SMA Patients -- With September PDUFA
Seeking Alpha · 06/25 13:33
S&P 500 Futures Climb In Premarket Trading; Bio-Techne, Micron Technology Lead
Dow Jones · 06/25 11:30
More
About SRRK
Scholar Rock Holding Corporation is a biopharmaceutical company. The Company focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe and debilitating neuromuscular diseases. Its pipeline product candidates include apitegromab, a subcutaneous formulation of apitegromab, and SRK-439. The Apitegromab is an investigational fully human, intravenously administered monoclonal antibody designed to inhibit myostatin activation by selectively binding the pro- and latent forms of myostatin in the skeletal muscle. The SRK-439, is an investigational, subcutaneously administered fully human anti-pro/latent myostatin antibody that has high inhibitory potency while maintaining selectivity towards myostatin. Its early-stage pipeline includes additional programs for the treatment of patients with rare, severe, and debilitating neuromuscular diseases.

Webull offers Scholar Rock Holding Corp stock information, including NASDAQ: SRRK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRRK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SRRK stock methods without spending real money on the virtual paper trading platform.